AWHP provided comment ahead of a public workshop on the use of pharmacotherapy to address obesity among Nevada Medicaid beneficiaries.

AWHP urged members of the New Hampshire Senate Health and Human Services Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP urged members of the New Hampshire House of Representatives Health, Human Services and Elderly Affairs Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP urged New Hampshire Governor Kelly Ayotte to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP submitted comments to the CDC’s ACIP ahead of its December 2025 meeting urging the importance of evidence-based vaccine science, of the hepatitis B vaccine for newborns, and the continued recommendation of combination vaccines.

AWHP submitted comments to the HRSA-supported Women’s Preventive Services Initiative (WPSI) on their Draft Cervical Cancer Screening Recommendations.

AWHP submitted comments to the CDC’s ACIP ahead of its September 2025 meeting urging it to prioritize a return to a federal vaccine framework that is centered
in decades of established science and that preserves access and puts forth clear, simple guidance.

AWHP sent letters of thanks to several members of the House for their support for a letter to CMS urging obesity care coverage expansion, and urged them to consider supporting TROA as well.

AWHP sent letters of thanks to Reps. Conaway and Thompson for both their support for a letter to CMS urging obesity care coverage expansion as well as their ongoing support of TROA.